share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

福泰製藥 | 4:持股變動聲明-高管 Bozic Carmen
美股SEC公告 ·  05/31 16:33
Moomoo AI 已提取核心訊息
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 2,280 shares of common stock on May 29, 2024. The transaction was executed at a price of $445.56 per share, resulting in a total sale value of approximately $1,015,876.80. Following the sale, Bozic's direct holdings in the company amount to 34,659 shares. The sale took place through an open market transaction, as reported in the company's latest filing.
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 2,280 shares of common stock on May 29, 2024. The transaction was executed at a price of $445.56 per share, resulting in a total sale value of approximately $1,015,876.80. Following the sale, Bozic's direct holdings in the company amount to 34,659 shares. The sale took place through an open market transaction, as reported in the company's latest filing.
Vertex Pharmicals Inc.(VRTX)執行副總裁兼首席營銷官卡門·博齊奇於2024年5月29日完成了2,280股普通股的出售。該交易以每股445.56美元的價格執行,總銷售價值約爲1,015,876.80美元。出售後,Bozic在該公司的直接持股量爲34,659股。據該公司最新文件所述,此次出售是通過公開市場交易進行的。
Vertex Pharmicals Inc.(VRTX)執行副總裁兼首席營銷官卡門·博齊奇於2024年5月29日完成了2,280股普通股的出售。該交易以每股445.56美元的價格執行,總銷售價值約爲1,015,876.80美元。出售後,Bozic在該公司的直接持股量爲34,659股。據該公司最新文件所述,此次出售是通過公開市場交易進行的。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息